| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| E T Lim, T Berger, M Reindl, C M Dalton, K Fernando, G Keir, E J Thompson, D H Miller, G Giovannon. Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 11. issue 4. 2005-09-26. PMID:16042235. |
this study investigates whether the presence of serum and plasma anti-myelin oligodendrocyte glycoprotein (mog) and anti-myelin basic protein (mbp) in patients presenting with a clinically isolated syndrome compatible with demyelination (cis) predicts early conversion to multiple sclerosis (ms). |
2005-09-26 |
2023-08-12 |
Not clear |
| Kajsa Wing, Pia Larsson, Kerstin Sandström, Samuel B Lundin, Elisabeth Suri-Payer, Anna Rudi. CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology. vol 115. issue 4. 2005-09-20. PMID:16011520. |
while cd4+cd25- thymocytes proliferated in response to myelin oligodendrocyte glycoprotein (mog), tetanus toxoid and beta-lactoglobulin, suppression of proliferation was not detected after the addition of thymic cd25+ treg. |
2005-09-20 |
2023-08-12 |
human |
| Dan Frenkel, Zhihong Huang, Ruth Maron, Djordje N Koldzic, Michael A Moskowitz, Howard L Weine. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. Journal of the neurological sciences. vol 233. issue 1-2. 2005-08-22. PMID:15894335. |
in this work we demonstrate the reduction of infarct size following mucosal tolerance by myelin oligodendrocyte glycoprotein (mog) (35-55) peptide in mouse stroke model. |
2005-08-22 |
2023-08-12 |
mouse |
| Paul A Smith, Margaret Morris-Downes, Nicole Heijmans, Gareth Pryce, Elizabeth Arter, Janet K O'Neill, Bert 't Hart, David Baker, Sandra Amo. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Journal of neuroimmunology. vol 164. issue 1-2. 2005-08-22. PMID:15927270. |
myelin oligodendrocyte glycoprotein (mog 8-21) induces relapsing eae in abh mice characterized by broadening of the autoimmune reportoire. |
2005-08-22 |
2023-08-12 |
mouse |
| P G Bannerman, A Hahn, S Ramirez, M Morley, C Bönnemann, S Yu, G-X Zhang, A Rostami, D Pleasur. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. Brain : a journal of neurology. vol 128. issue Pt 8. 2005-08-16. PMID:15901645. |
using adult male c57bl/6 mice that express a yellow fluorescent protein transgene in their motor neurons, we induced experimental autoimmune encephalomyelitis (eae) by immunization with myelin oligodendrocyte glycoprotein peptide 35-55 (mog peptide) in complete freund's adjuvant (cfa). |
2005-08-16 |
2023-08-12 |
mouse |
| Francesco Angelucci, Massimiliano Mirabella, Giovanni Frisullo, Marcella Caggiula, Pietro Attilio Tonali, Anna Paola Batocch. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy. Disease markers. vol 21. issue 2. 2005-07-28. PMID:15920290. |
in this study the serum levels of anti-myelin oligodendrocyte glycoprotein (mog) (directed against the epitopes 1-26 and 15-40) and anti-myelin basic protein (mbp) antibodies were sequentially measured in the same ms patient either in relapse or remission phases. |
2005-07-28 |
2023-08-12 |
Not clear |
| Anthony P Nicholas, Thiagarajan Sambandam, Joshua D Echols, Scott R Barnu. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. The Journal of comparative neurology. vol 486. issue 3. 2005-07-15. PMID:15844173. |
in this study, we demonstrate for the first time the immunohistochemical expression of citrullinated proteins in the central nervous system (cns) of mice with myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae). |
2005-07-15 |
2023-08-12 |
mouse |
| Ralf A Linker, Evelyn Rott, H H Hofstetter, T Hanke, Klaus V Toyka, Ralf Gol. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiology of disease. vol 19. issue 1-2. 2005-07-12. PMID:15837577. |
we investigated the role of mhc-i and cd8+ t-cells by studying experimental autoimmune encephalomyelitis (eae) in beta-2 microglobulin knockout mice induced by myelin oligodendrocyte glycoprotein (mog) peptide 35-55 or whole rat myelin basic protein (rmbp). |
2005-07-12 |
2023-08-12 |
mouse |
| Ryuji Terayama, Yoshio Bando, Ying-Ping Jiang, Branka Mitrovic, Shigetaka Yoshid. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis. Neuroscience letters. vol 382. issue 1-2. 2005-07-11. PMID:15911126. |
to determine the possible involvement of protease m/neurosin in demyelinating diseases of the cns, we examined its expression in myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae), a recognized animal model of multiple sclerosis (ms). |
2005-07-11 |
2023-08-12 |
mouse |
| Paul A Smith, Nicole Heijmans, Boudewijn Ouwerling, Esther C Breij, Nicholas Evans, Johannes M van Noort, Arianne C Plomp, Cécile Delarasse, Bert 't Hart, Danielle Pham-Dinh, Sandra Amo. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. European journal of immunology. vol 35. issue 4. 2005-06-16. PMID:15761848. |
myelin oligodendrocyte glycoprotein (mog) is a powerful encephalitogen for experimental autoimmune demyelination. |
2005-06-16 |
2023-08-12 |
mouse |
| Lars Siim Madsen, Palle Christophersen, Søren-Peter Olese. Blockade of Ca2+-activated K+ channels in T cells: an option for the treatment of multiple sclerosis? European journal of immunology. vol 35. issue 4. 2005-06-16. PMID:15770695. |
demonstrate that selective blockade of the intermediate-conductance ca(2+)-activated k(+) channel (the ik channel encoded by the kcnn4 gene) prevents cytokine production in the spinal chord and ameliorates the development of eae caused by injection of myelin oligodendrocyte glycoprotein (mog)(35-55) in mice. |
2005-06-16 |
2023-08-12 |
mouse |
| Eran Nizri, Rellie Adani, Haim Meshulam, Gabi Amitai, Talma Brenne. Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments. Neuroscience letters. vol 376. issue 1. 2005-06-14. PMID:15694272. |
the compounds were tested for their efficiency in reducing the neurological symptoms observed in experimental autoimmune encephalomyelitis induced in mice by myelin oligodendrocyte glycoprotein (mog). |
2005-06-14 |
2023-08-12 |
mouse |
| M B Sättler, D Merkler, K Maier, C Stadelmann, H Ehrenreich, M Bähr, R Die. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell death and differentiation. vol 11 Suppl 2. 2005-06-09. PMID:15459752. |
in the present study, we show that, in rats suffering from myelin oligodendrocyte glycoprotein (mog)-induced optic neuritis, systemic application of erythropoietin (epo) significantly increased survival and function of retinal ganglion cells (rgcs), the neurons that form the axons of the optic nerve. |
2005-06-09 |
2023-08-12 |
rat |
| Petra Kleindienst, Carsten Wiethe, Manfred B Lutz, Thomas Brocke. Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells. Journal of immunology (Baltimore, Md. : 1950). vol 174. issue 7. 2005-06-07. PMID:15778350. |
pretreatment of c57bl/6 mice with encephalitogenic myelin oligodendrocyte glycoprotein (mog)(35-55) peptide-loaded semimature dc protected from mog-induced autoimmune encephalomyelitis. |
2005-06-07 |
2023-08-12 |
mouse |
| Annette van der Goes, Wiebe Boorsma, Karin Hoekstra, Lisette Montagne, Corline J A de Groot, Christine D Dijkstr. Determination of the sequential degradation of myelin proteins by macrophages. Journal of neuroimmunology. vol 161. issue 1-2. 2005-05-27. PMID:15748939. |
demonstration of different myelin proteins (myelin basic protein [mbp], proteolipid protein [plp] and myelin oligodendrocyte glycoprotein [mog]) is used as a tool to determine the stage of ms lesions in autopsy tissue. |
2005-05-27 |
2023-08-12 |
human |
| Saad Muhallab, Ingrid Dahlman, Erik Wallströ. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 161. issue 1-2. 2005-05-27. PMID:15748954. |
immunization with recombinant myelin oligodendrocyte glycoprotein (a.a.1-125; mog)/ifa induced eae in strains expressing the mhc class ii allele rt1.b(n), whereas strains expressing the rt1.b(l) were resistant. |
2005-05-27 |
2023-08-12 |
rat |
| Muriel B Sättler, Ricarda Diem, Doron Merkler, Iris Demmer, Ina Boger, Christine Stadelmann, Mathias Bäh. Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis. Experimental neurology. vol 193. issue 1. 2005-05-24. PMID:15817275. |
we demonstrated previously that myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis in rats provokes severe axonal and neuronal injury even before clinical manifestation of the disease. |
2005-05-24 |
2023-08-12 |
rat |
| Dusanka S Skundric, Rujuan Dai, Vaagn L Zakarian, Denise Bessert, Robert P Skoff, William W Cruikshank, Zlatan Kurjakovi. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Journal of neuroscience research. vol 79. issue 5. 2005-05-09. PMID:15682385. |
we reported that (b6xsjl) f1 (h-2b/s) mice with severe relapsing-remitting disease had extensive infiltration by cd4+ t cells compared to that in c57bl/6 (b6) (h-2b) mice, which developed mild low-relapsing disease in response to myelin oligodendrocyte peptide 35-55 (mog(35-55)). |
2005-05-09 |
2023-08-12 |
mouse |
| G Zai, N King, K Wigg, J Couto, G W H Wong, W G Honer, C L Barr, J L Kenned. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes, brain, and behavior. vol 4. issue 1. 2005-04-29. PMID:15660663. |
genetic study of the myelin oligodendrocyte glycoprotein (mog) gene in schizophrenia. |
2005-04-29 |
2023-08-12 |
human |
| G Zai, N King, K Wigg, J Couto, G W H Wong, W G Honer, C L Barr, J L Kenned. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes, brain, and behavior. vol 4. issue 1. 2005-04-29. PMID:15660663. |
the myelin oligodendrocyte glycoprotein (mog) gene, which is located close to the hla region, is considered a candidate for scz due to its association with white matter abnormalities and its importance in mediating the complement cascade. |
2005-04-29 |
2023-08-12 |
human |